Hematopoietic Stem Cell Transplantation (HSCT) Market, Global Outlook and Forecast 2022-2028

0
15

This report contains market size and forecasts of Hematopoietic Stem Cell Transplantation (HSCT) in Global, including the following market information:
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hematopoietic Stem Cell Transplantation (HSCT) market was valued at 2487.2 million in 2021 and is projected to reach US$ 3607.2 million by 2028, at a CAGR of 5.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allogeneic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hematopoietic Stem Cell Transplantation (HSCT) include Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc and ViaCord Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hematopoietic Stem Cell Transplantation (HSCT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematopoietic Stem Cell Transplantation (HSCT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Segment Percentages, by Type, 2021 (%)
Allogeneic
Autologous
Global Hematopoietic Stem Cell Transplantation (HSCT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Segment Percentages, by Application, 2021 (%)
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Cord Blood Transplant (CBT)
Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematopoietic Stem Cell Transplantation (HSCT) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hematopoietic Stem Cell Transplantation (HSCT) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regen Biopharma Inc
China Cord Blood Corp
CBR Systems Inc
Escape Therapeutics Inc
Cryo-Save AG
Lonza Group Ltd
Pluristem Therapeutics Inc
ViaCord Inc

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.